Fidelity Investments β 2022 Investments
8 investments dated 2022 Β· listed companies and verified rows first Β· show all
Castle Creek Biosciences develops re-dosable gene therapies for genetic diseases, with a lead candidate (D-Fi) in registrational clinical trials for dystrophic epidermolysis bullosa.
BiotechDeep TechMedical DevicesExton, US
Matthew Gantz(President and Chief Executive Officer)inDavid ChuinMichael TownsleyChristopher J. LarsoninRhea WilliamsinJude Sullivan(Executive Officer)
Co-investorsParagon Biosciences LLCValor Equity PartnersHorizon
Creditas is a Brazilian financial platform offering secured loans (using vehicles or real estate as collateral), payroll loans, auto and home financing, insurance, and flexible employee benefits.
ConsumerFintechInsurTech
Sergio Furio(Founder)in
Co-investorsAmadeus Capital PartnersHeadlineHeadline Growth Management, LLCKaszek VenturesLightrockMouro Capital+12 more
Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome.
BiotechMedical Devices
Co-investorsParagon Biosciences LLCBain Capital Life SciencesValor Equity Partners
Fanatics is an online retailer of officially licensed sports merchandise, selling jerseys, apparel, headwear, collectibles, and team gear across leagues including the NFL, MLB, NBA, NHL, NCAA, MLS, Formula 1, and NASCAR.
ConsumerE-commerceSports TechJacksonville, US
Michael G. Rubin(Mr. Rubin is the Chief Executive Officer of the Issuer.)inMichael Rubin(Founder)inF. Douglas Mack(Director)Caren Yeamans(Ms. Yeamans is the Secretary of the Issuer.)Glenn H. Schiffman(Executive Officer)David Tucker Kain(Director)
Co-investorsAndreessen HorowitzDarco CapitalG SquaredInsight PartnersLakeside CapitalPrysm Capital+6 more
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Gregory L. Verdine(Executive Officer, Director)Gregory Verdine, Ph.D.
BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)
Co-investorsARCH Venture PartnersGV (Google Ventures)Blue Pool Capital
Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.
Digital HealthHealthtechMclean, US
Ikenna Okezie(Executive Officer, Director)inAlexander Houlday(Executive Officer)inStacey Queen-Pyndell(Executive Officer)Larry Renfro(Interim President & CEO)
BoardAnna Haghgooie(Director)Anthony Welters(Director)
Co-investorsFlare Capital PartnersOptum VenturesHealthQuest CapitalBlue Venture FundsDefy PartnersLongitude Capital+7 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.